We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Mechanism Explains Increased Insulin Resistance in Type II Diabetes

By LabMedica International staff writers
Posted on 11 Apr 2012
A recent paper outlined the molecular mechanism that makes the p75 neurotrophin receptor (p75NTR) a key regulator of glucose uptake and insulin resistance and suggested a possible new therapeutic approach for the treatment of type II diabetes.

Investigators at the University of California, San Francisco (USA) identified p75NTR as being associated with glucose regulation due to its location in fat and muscle tissue and its participation in many aspects of cell metabolism. More...
To examine more precisely the role of p75NTR they genetically engineered a line of mice to lack the gene that produces this protein.

Results published in the March 28, 2012, online edition of the journal Proceedings of the [US] National Academy of Sciences revealed that compared to normal animals, the p75NTR “knockout” mice demonstrated increased insulin sensitivity on normal chow diet, independent of changes in body weight. Deletion of the p75NTR gene increased the insulin-stimulated glucose disposal rate and suppression of hepatic glucose production.

Other mice were manipulated to overexpress p75NTR in their adipocytes. In these animals, insulin-stimulated glucose transport was decreased. In adipocytes, p75NTR was found to form a complex with the Rab5 family GTPases Rab5 and Rab31 that regulate the activity of the glucose transport protein GLUT4. Rab5 and Rab31 directly interacted with p75NTR primarily via helix 4 of the p75NTR death domain. Adipocytes from p75NTR knockout mice showed increased Rab5 and decreased Rab31 activities, and dominant negative Rab5 rescued the increase in glucose uptake seen in p75NTR knockout adipocytes.

“We identified that p75NTR is a unique player in glucose metabolism,” said senior author Dr. Katerina Akassoglou, associate professor of neurology at the University of California, San Francisco. “Therapies targeted at p75NTR may represent a new therapeutic approach for diabetes, and our studies of p75NTR's unanticipated role in regulating glucose metabolism suggest a new target for drug therapies. Future work is needed to test whether this finding may translate into a potential treatment.”

Related Links:
University of California, San Francisco




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Thyroid Test
Anti-Thyroid EIA Test
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.